A detailed history of Cim Investment Management Inc transactions in Incyte Corp stock. As of the latest transaction made, Cim Investment Management Inc holds 6,018 shares of INCY stock, worth $442,443. This represents 0.12% of its overall portfolio holdings.

Number of Shares
6,018
Previous 6,123 1.71%
Holding current value
$442,443
Previous $371,000 7.01%
% of portfolio
0.12%
Previous 0.12%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

SELL
$57.33 - $68.61 $6,019 - $7,204
-105 Reduced 1.71%
6,018 $397,000
Q2 2024

Aug 15, 2024

SELL
$51.18 - $63.75 $1,791 - $2,231
-35 Reduced 0.57%
6,123 $371,000
Q4 2023

Feb 15, 2024

SELL
$52.16 - $64.19 $49,812 - $61,301
-955 Reduced 13.43%
6,158 $386,000
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $8,376 - $9,559
-145 Reduced 2.0%
7,113 $410,000
Q2 2023

Aug 09, 2023

BUY
$60.95 - $75.51 $914 - $1,132
15 Added 0.21%
7,258 $451,000
Q1 2023

May 16, 2023

BUY
$70.23 - $86.01 $20,928 - $25,630
298 Added 4.29%
7,243 $523,000
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $11,219 - $14,046
-167 Reduced 2.35%
6,945 $557,000
Q3 2022

Nov 14, 2022

BUY
$66.18 - $82.86 $470,672 - $589,300
7,112 New
7,112 $474,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Cim Investment Management Inc Portfolio

Follow Cim Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.